Evidence map›Paper›PMID 38062535›Full record

ArticleResearch involvement and engagement2023

Patient Engagement in Research Scale (PEIRS-22): Danish translation, applicability, and user experiences.

Mille Guldager Christiansen, Helle Pappot, Clayon Hamilton, Trine Lund-Jacobsen, Anne Wilhøft Kristensen, Sara Nordentoft, Beverley Lim Høeg, Pernille Bidstrup, Iben Husted Nielsen, Jane Ulstrup and 3 more

Abstract read
In one paragraph

Article in Research involvement and engagement, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mille Guldager ChristiansenDepartment of Oncology, Center for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark. mille.guldager.christiansen@regionh.dk.ORCID http://orcid.org/0000-0002-1507-1130
Helle PappotDepartment of Oncology, Center for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark.ORCID http://orcid.org/0000-0003-2337-9511
Clayon HamiltonBC Mental Health and Substance Use Service at Provincial Health Service Authority, Simon Fraser University, British Columbia, Canada.ORCID http://orcid.org/0000-0002-6852-3436
Trine Lund-JacobsenDepartment of Endocrinology, Center for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark.ORCID http://orcid.org/0000-0002-3616-5929
Anne Wilhøft KristensenDanish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-5367-0794
Sara NordentoftDepartment of Neurosurgery, Center for Neuroscience, Copenhagen University Hospital, Rigshospitalet, Denmark.ORCID http://orcid.org/0000-0001-5600-2644
Beverley Lim HøegPsychological Aspects of Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-9946-2429
Pernille BidstrupPsychological Aspects of Cancer Research Group, Danish Cancer Society Research Center, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-9704-6800
Iben Husted NielsenDepartment of Hematology, Center for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark.ORCID http://orcid.org/0000-0001-7618-3729
Jane Ulstrup, Copenhagen, Denmark.
Anouk Kirsten TripDanish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-9600-6236
Mary JardenDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-3040-8384
Karin PiilDepartment of Oncology, Center for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark.ORCID http://orcid.org/0000-0001-7972-4674

Funding

Novo Nordisk Fonden 0065353
6 · The paper itself

Abstract

backgroundPatient and Public Involvement (PPI) in health research is gaining increased attention and acceptance worldwide. Reliable measurements are crucial to accurately assess, monitor, and evaluate patient involvement efforts in research. The Patient Engagement in Research Scale (PEIRS-22) measures meaningful patient and family caregiver engagement in research. This study focuses on three primary objectives: (1) translation of the PEIRS-22 from English to Danish, followed by linguistic validation and cultural adaptation; (2) assessing the applicability of the Danish PEIRS-22; and (3) focus group interviews to explore the user experiences of PPI.

methodsA three-phase multi-method study was conducted. In phase one, the PEIRS-22 was translated, linguistically validated and culturally adapted to Danish. In phase two individuals from three distinct patient cancer advisory boards responded to the Danish version of PEIRS-22 to assess its applicability. Three focus group interviews were conducted in phase three, involving individuals from three patient cancer advisory boards.

resultsThe translation process resulted in a Danish version of PEIRS-22, conceptually and culturally equivalent to the English version. Overall, among individuals of the three advisory boards (n = 15) the applicability was found to be satisfactory, with no missing data and all items completed. The total PEIRS-22 score among the three advisory boards was 85.2 out of a possible 100, with higher scores indicating greater meaningful involvement. A nested sample of the three patient cancer advisory boards (n = 9) participated in focus group interviews. The analysis yielded four themes: (1) The Danish PEIRS-22 captured the intended cultural meaning and contributed to self-reflection, (2) Internal motivation is a driver for involvement (3), Involvement brought a personal sense of empowerment and (4) Meaningful involvement collaborations are fostered by a trustful atmosphere.

conclusionsThe PEIRS-22 questionnaire has been translated, linguistically validated, and culturally adapted into Danish. We propose that the PEIRS-22 is now ready for use in Danish populations. This study provides a Danish version of the questionnaire that can be used to develop patient-centred practices and foster meaningful involvement and collaborations between patients and researchers in the field of cancer research in Denmark. Personal benefits of participating in PPI can vary, and we recommend using PEIRS-22 in conjunction with a qualitative approach to better explore perspectives on meaningful involvement.

trial registrationThe study was registered prospectively on October 22, 2022, by the Danish Data Protection Agency (jr. nr. P-2022-528).

Indexed as

DanishFocus groupsPatient and Public InvolvementPatient engagementPatient Engagement in Research ScalePEIRS-22

Identifiers

PMID38062535
PMCPMC10704757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.